Results 221 to 230 of about 457,954 (260)

The HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer. [PDF]

Mol Cell
Hubbi ME, Wang CL, Suhail Y, Almasri NL, Xie J, Hollander EE, Kshitiz, Muir A, Stanger BZ, Dang CV.   +9 more
europepmc   +1 more source

Pancreatic Cancer Risk in Patients With Low-Risk Cystic Lesions.

JAMA Netw Open
Haj Mirzaian A, Abbasi N, Kambadakone AR, Lacson R, Hernandez-Barco YG, Jin DX, Jajoo K, Bates DW, Khorasani R.   +8 more
europepmc   +1 more source

Atypical Lung Metastases From Pancreatic Cancer. [PDF]

Respirol Case Rep
Sato R, Fukuda Y, Ishida T.
europepmc   +1 more source

Retraction: GATA4 inhibits cell differentiation and proliferation in pancreatic cancer. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

GPSM2 Promotes Pancreatic Cancer Progression Through METTL3-Mediated m6A Modification of YAP1 mRNA. [PDF]

J Cell Mol Med
Xiu J, Qiao L, Li M, Hu X, Shen Z, Yang R, Zhang H, Dong Z, Liu X, Zhang Y.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pancreatic Cancer

Surgical Oncology Clinics of North America, 2021
Pancreatic ductal adenocarcinoma (PDAC) is a relatively uncommon cancer, with approximately 60 430 new diagnoses expected in 2021 in the US. The incidence of PDAC is increasing by 0.5% to 1.0% per year, and it is projected to become the second-leading cause of cancer-related mortality by 2030.Effective screening is not available for PDAC, and most ...
Wungki, Park, Akhil, Chawla, Eileen M, O'Reilly   +2 more
openaire   +5 more sources